Strong Support

For adults with type 2 diabetes and kidney problems, taking a weekly semaglutide shot (like Ozempic) cuts their risk of heart attack, stroke, or dying from heart issues by 18% compared to a dummy shot.

82
Pro
0
Against

Evidence from Studies

Supporting (1)

82

Community contributions welcome

The study tested the same diabetes medicine (semaglutide) in similar patients and found it reduced heart problems by 18%, just like the claim says.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.